Mobithron® P chứa chiết xuất tự nhiên giàu hyaluronic axit. Hyaluronic acid, thành phần chính của chất lỏng hoạt dịch. Một trong những vai trò quan trọng nhất của axit hyaluronic trong chất lỏng hoạt dịch là tăng độ nhớt và giảm ma sát giữa các bề mặt khớp, do đó đảm bảo hoạt động đúng của khớp (tạo lớp đệm, trơn tru, giảm ma sát). Mobithron® P chứa collagen loại II, một thành phần giúp khớp khỏe mạnh, tăng khả năng vận động và linh hoạt của khớp. Những thành phần này được hỗ trợ bởi nhiều nghiên cứu lâm sàng chứng minh có tác dụng bổ khớp.
Giá bán: 1200,000 / 1 hộp
Liên hệ: 09188.8.131.52
Osteoarthritis (OA), which entails the destruction of joint cartilage and remodeling of the adjacent bone, is the most common form of arthritis. Current therapies for OA include various over the counter analgesics, a number of non-steroidal anti-inflammatory drugs (NSAIDs), intra-articular injection of corticosteroids or hyaluronic acid etc. There are no curative therapies currently available for OA, individualized treatment programs are available to help relieve pain and stiffness, and to maintain and/or improve functional status. Mobithron P is NEW, DIFFERENT and BETTER than the current treatment options for the treatment of OA.
Mobithron P offers 3 mode of actions – Synthesizes hyaluronic acid, building the cartilage and control the underlying inflammation. Two key ingredients of Mobithron P – Hyaluronic Acid 45mg & Native Collagen Type II 10mg – have demonstrated its superior efficacy and safety in the treatment of OA in numerous clinical studies. David C et al has published a study in the International Journal of Medical Sciences 2009 and concluded that Mobithron P was 2-3 times more efficacious than glucosamine plus chondroitin in the treatment of moderate to severe OA and was well tolerated.
Water contributes up to 80% of the wet weight of articular cartilage. Collagens contribute about 60% of the dry weight of articular cartilage and collagen type II accounts for 90% to 95% of the articular cartilage collagen.Repeated oral administration of collagen type II induce oral tolerance and inhibit the development of collagen-induced arthritis.Undenatured (Native) collagen type II has been shown to protect the onset of joint damage in both OA and RA. This protection is hypothesized to occur via the induction and migration of T regulatory cell (Tregs) to the area of inflammation and damage.
Hyaluronic acid (HA) is present in synovial ﬂuid and in extracellular matrix of cartilage. HA is synthesized by human synoviocytes and chondrocytes, and is responsible for the viscosity of articular synovial ﬂuid. In patients with OA, the concentration of endogenous HA in synovial ﬂuid decreases signiﬁcantly. Mobithron P is the first oral hyaluronic acid. Mobithron P lubricates the joints, stimulating endogenous synthesis of hyaluronic acid and resulting in a 10-fold increase in its secretion into the synovial fluid.
Both key ingredients of Mobithron P have GRAS (Generally Recognized As Safe) by US FDA. Numerous scientific studies have shown that Mobithron P is safe and effective.
Mobithron P is in powder form (sachets), which can be taken once-daily before meal. In clinical studies conducted with patients suffering from OA, patients given Mobithron P noticed improvement in symptoms after only 1 month.Mobithron P does not have any reported drug-drug interactions.